Pediatr Nephrol 27:21232127
The Dangers of Ozempic, Wegovy, Rybelsus, and Other Weight Loss Drugs Ozempic, Wegovy, Rybelsus, manufactured by Novo Nordisk, as well as similar weight loss drugs like Mounjaro and Trulicity, manufactured by Eli Lilly and Company, carry potentially serious health risks
These findings underscore its potential as a senolytic agent with research applications in degenerative diseases, dermatology, and regenerative medicine
Noom argues for a personalized exception, but its unclear how the FDA will respond given the regulatory gray area around compounded GLP-1 drugs
Risks of improper disposal include: Injury : Loose needles can puncture skin, leading to serious injuries
Some studies indicate that tirzepatide may result in greater weight loss compared to semaglutide GLP-1, especially at higher doses